CJC-1295 + Ipamorelin
Blended GHRH analogue and selective ghrelin-receptor agonist.
- CAS
- 863288-34-0 / 170851-70-4
- Molecular weight
- 3647.2 g/mol / 711.85 g/mol
- Form
- Co-lyophilised blend, sealed vial
- Purity
- >99.0% by HPLC (each component)
- Sequence
- Modified GRF(1-29) blended with Aib-His-D-2-Nal-D-Phe-Lys-NH2
Free nationwide shipping over ₱7,000, otherwise flat ₱350. Sold for in-vitro laboratory research only — not for human or veterinary use.
Overview
This blend pairs CJC-1295, a growth-hormone-releasing hormone analogue, with Ipamorelin, a highly selective pentapeptide agonist at the growth hormone secretagogue receptor. The pairing is one of the most commonly requested combination research vials worldwide.
Each 10 mg vial is co-lyophilised under controlled conditions so both components remain in a fixed, reproducible ratio across every batch.
Handling & storage
- Reconstitute gently; blends are sensitive to mechanical agitation.
- Store lyophilised at -20°C, reconstituted at 2-8°C.
- Aliquot to avoid repeated puncture of the stopper.
Research areas
Researchers examine the additive effect of GHRH-receptor stimulation alongside ghrelin-receptor agonism on pulsatile secretion models.
Ipamorelin is characterised in literature for minimal cross-reactivity with cortisol and prolactin pathways.
CJC-1295 without DAC demonstrates a short plasma half-life in published pharmacokinetic models.
